Evaluating the Logistics, Safety, and Survival Outcomes of Whole Blood Versus Packed Red Blood Cells Administered by Ground Paramedics or Flight Crews in Haemorrhagic Shock: A Systematic Review
This systematic review of 18 studies involving over 3,000 trauma patients indicates that prehospital administration of whole blood by ground or flight crews significantly improves survival and coagulation outcomes compared to packed red blood cells, though widespread implementation requires addressing logistical challenges and further validation through randomized controlled trials.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a person suffers a severe injury that causes them to lose a dangerous amount of blood, their body faces a double crisis. First, the heart struggles to pump enough fluid to keep the brain and organs alive. Second, the blood that remains loses its ability to clot, turning a manageable wound into a runaway leak. For decades, the standard way to fix the first problem outside of a hospital was to give patients saltwater solutions to fill their veins. While this buys a little time, it does nothing to stop the bleeding or replace the clotting factors the body desperately needs. More recently, medical teams have started carrying bags of packed red blood cells, which are excellent at restoring oxygen but still lack the clotting power needed to halt the bleeding. A different approach, once common in military field hospitals and now making a comeback in civilian emergency care, is to use whole blood. This is a single bag containing red cells, plasma, and platelets in the exact proportions the human body uses naturally, offering a complete package to fight both shock and bleeding at the same time.
The question facing emergency services today is whether this whole blood approach works as well when delivered by paramedics on the ground or flight crews in helicopters as it does in the controlled chaos of a battlefield. To answer this, a team of researchers from Australia, Saudi Arabia, and Saudi Arabia conducted a massive review of existing medical studies. They gathered data from eighteen different reports published between 2017 and 2024, covering more than 3,100 adult patients who were in shock due to bleeding. These patients were treated by emergency teams either on the ground or in the air, and the researchers compared those who received whole blood against those who received the standard packed red blood cells. The goal was to see if the whole blood actually helped people survive longer, if it was safe to use in unpredictable environments, and if the complex logistics of keeping blood cold and fresh were manageable for emergency crews.
The results of this review point toward a clear advantage for whole blood. When the researchers looked at who survived the first twenty-four hours after treatment, the patients who received whole blood were significantly more likely to be alive than those who received packed red blood cells alone. This survival benefit held true whether the patient was treated by a ground ambulance crew or a helicopter team, though the advantage appeared slightly stronger for the helicopter crews. The benefit extended to the first thirty days as well, with whole blood patients showing lower death rates. Beyond just staying alive, the blood of patients who received whole blood showed signs of better clotting function when they arrived at the hospital. Their blood was better able to stop bleeding naturally, suggesting that the single bag of whole blood provided the missing ingredients that packed red blood cells simply could not.
Safety was another major concern, as giving blood to a patient whose blood type is unknown carries inherent risks. The review found that serious reactions to the transfusion were rare and occurred at similar low rates in both groups. The specific type of whole blood used in almost all these studies was low-titer group O blood, which is carefully screened to ensure it does not attack the recipient's blood cells. The data showed that dangerous reactions, such as lung injuries or immune system attacks on the blood, were uncommon and did not happen more often with whole blood than with the standard treatment. This suggests that the fear of using whole blood in the field is not supported by the evidence, provided the blood is handled correctly.
However, the path to using whole blood is not without its practical hurdles. The most significant challenge is keeping the blood cold. Whole blood must be stored between one and six degrees Celsius to remain safe and effective. Helicopter crews generally found this easier to manage because they have more space for specialized cooling equipment and often fly in more controlled environments. Ground ambulance crews faced greater difficulties, especially in hot climates where the ambient heat could warm the blood faster than the cooling units could handle. The short shelf life of the product, which is only twenty-one days, also created a logistical puzzle. If a service does not use the blood quickly enough, it expires and must be thrown away, leading to waste. The review noted that wastage rates varied, but higher-volume services wasted less. Despite these challenges, the researchers found that with the right training and infrastructure, emergency crews could successfully manage the storage and administration of whole blood without breaking safety rules or running out of supplies.
The authors of the review emphasize that while the evidence is promising, it is not yet a final verdict. Most of the studies they analyzed were observational, meaning they looked back at records of patients who had already been treated, rather than running a controlled experiment where patients were randomly assigned to one group or the other. This means there is a small chance that the patients who received whole blood were simply the ones who were easier to save to begin with. The one randomized trial included in the review was too small to prove the survival benefit statistically, though it showed a trend in the same direction. The researchers conclude that whole blood appears to offer real benefits in survival and clotting, and that it is safe to use in the field, but they call for larger, more rigorous experiments to confirm these findings with absolute certainty. Until such proof is available, emergency services are left with a difficult choice: wait for perfect data or act on the strong signals that whole blood is already saving lives. The review suggests that the current evidence is strong enough to justify serious planning for its use, particularly in helicopter services where the logistics are most manageable.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.